Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF‐κВ and WNT Signaling
Source abstract
Abstract
Abstract Terminally differentiated cells are commonly regarded as the most stable cell state in adult organisms, characterized by growth arrest while fulfilling their specialized functions. A better understanding of the mechanisms involved in promoting cell cycle exit will improve the ability to differentiate pluripotent cells into mature tissues for both pharmacological and therapeutic use. Here, it demonstrates that a hyperosmolar environment enforces a protective p53‐independent quiescent state in immature hepatoma cells and in pluripotent stem cell‐derived models of human hepatocytes and endothelial cells. Prolonged culture in hyperosmolar conditions stimulates changes in gene expression promoting functional cell maturation. Interestingly, hyperosmolar conditions do not only trigger growth arrest and cellular maturation but are also necessary to maintain this maturated state, as switching back to plasma osmolarity reverses the changes in expression of maturation and proliferative markers. Transcriptome analysis revealed sequential stages of osmolarity‐regulated growth arrest followed by cell maturation, mediated by activation of NF‐κВ, and repression of WNT signaling, respectively. This study reveals that a modulated increase in osmolarity serves as a biochemical signal to promote long‐term growth arrest and cellular maturation into different lineages, providing a practical method to generate differentiated hiPSCs that resemble their mature counterpart more closely.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Aldose Reductase and Taurine · Nerve injury and regeneration · Neurogenesis and neuroplasticity mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
KU Leuven Department of Development and Regeneration Stem Cell Institute Herestraat 49 Leuven 3000 Belgium
Laboratory of Endometrium, Endometriosis and Reproductive Medicine Department of Development and Regeneration KU Leuven Herestraat 49 Leuven 3000 Belgium
Liver Cell Biology Research Group Vrije Universiteit Brussel Laarbeeklaan 103 Brussels 1090 Belgium
Funding
Horizon 2020 Framework Programme · Onderzoeksraad, KU Leuven · Fonds Wetenschappelijk Onderzoek
References (100+)
Show source-provided references
1. 10.14712/fb202106702007010.14712/fb2021067020070 ↗
2. 10.1006/jtbi.1998.073110.1006/jtbi.1998.0731 ↗
3. 10.1186/1476-4598-1-810.1186/1476-4598-1-8 ↗
4. 10.1371/journal.pone.011559710.1371/journal.pone.0115597 ↗
5. 10.1038/nature1301310.1038/nature13013 ↗
6. 10.1152/physiolgenomics.00068.202010.1152/physiolgenomics.00068.2020 ↗
7. 10.1073/pnas.191590511610.1073/pnas.1915905116 ↗
8. 10.1016/j.cell.2006.07.02410.1016/j.cell.2006.07.024 ↗
9. 10.1038/srep3531610.1038/srep35316 ↗
10. Li F. · Am. J. Transl. Res. · 2016 · 8 · 4791
11. 10.1016/j.biomaterials.2016.12.00710.1016/j.biomaterials.2016.12.007 ↗
12. 10.1089/ten.tea.2014.025110.1089/ten.tea.2014.0251 ↗
13. 10.1530/REP-09-030010.1530/REP-09-0300 ↗
14. 10.1038/s41598-019-45352-310.1038/s41598-019-45352-3 ↗
15. 10.1016/j.bone.2012.11.03210.1016/j.bone.2012.11.032 ↗
16. Lima A. F. · Sci. Rep. · 2018 · 8 · 1
17. 10.1002/bit.26037101510.1002/bit.260371015 ↗
18. 10.1159/00005991310.1159/000059913 ↗
19. 10.1159/00009632410.1159/000096324 ↗
20. 10.1681/ASN.201012128410.1681/ASN.2010121284 ↗
21. 10.1073/pnas.040313910110.1073/pnas.0403139101 ↗
22. 10.1586/eem.10.310.1586/eem.10.3 ↗
23. 10.1038/s41575-019-0134-x10.1038/s41575-019-0134-x ↗
24. 10.1152/physrev.00056.200610.1152/physrev.00056.2006 ↗
25. 10.1007/s00441010035810.1007/s004410100358 ↗
26. 10.1167/iovs.07-114210.1167/iovs.07-1142 ↗
27. 10.1016/0014-4827(86)90542-210.1016/0014-4827(86)90542-2 ↗
28. 10.1016/j.bcp.2006.07.00210.1016/j.bcp.2006.07.002 ↗
29. 10.1073/pnas.96.13.721410.1073/pnas.96.13.7214 ↗
30. 10.4049/jimmunol.169.10.547710.4049/jimmunol.169.10.5477 ↗
31. Jin M. · 2011
32. Jabari S. · Int. J. Oncol. · 2009 · 35 · 69
33. 10.1038/s41467-020-15058-610.1038/s41467-020-15058-6 ↗
34. 10.1007/s00540-020-02795-710.1007/s00540-020-02795-7 ↗
35. 10.1097/00044067-200504000-0001110.1097/00044067-200504000-00011 ↗
36. 10.1074/jbc.RA117.00116710.1074/jbc.RA117.001167 ↗
37. 10.1089/scd.2019.006410.1089/scd.2019.0064 ↗
38. 10.1186/s13227-019-0142-510.1186/s13227-019-0142-5 ↗
39. 10.1242/jcs.19516410.1242/jcs.195164 ↗
40. 10.7554/eLife.1372210.7554/eLife.13722 ↗
41. 10.1371/journal.pbio.100056010.1371/journal.pbio.1000560 ↗
42. 10.1038/ncomms1472810.1038/ncomms14728 ↗
43. 10.1152/ajpcell.1999.276.4.C86510.1152/ajpcell.1999.276.4.C865 ↗
44. Hou Y. · 2020 · 21
45. 10.1073/pnas.98.4.199910.1073/pnas.98.4.1999 ↗
46. Luo L. · Invest Ophthalmol Vis Sci. · 2004 · 45 · 3758
47. 10.1042/BSR2019171110.1042/BSR20191711 ↗
48. 10.1021/acs.jproteome.6b0060210.1021/acs.jproteome.6b00602 ↗
49. 10.1016/j.celrep.2022.11039510.1016/j.celrep.2022.110395 ↗
50. 10.1038/s41419-019-2182-010.1038/s41419-019-2182-0 ↗
51. 10.1016/j.jhep.2019.06.03010.1016/j.jhep.2019.06.030 ↗
52. 10.1016/j.colsurfb.2020.11146610.1016/j.colsurfb.2020.111466 ↗
53. 10.3390/cells1004081210.3390/cells10040812 ↗
54. 10.1002/hep.2335410.1002/hep.23354 ↗
55. Tomaz R. A. · Elife · 2022 · 11
56. 10.1007/978-1-62703-348-0_1110.1007/978-1-62703-348-0_11 ↗
57. 10.1016/j.stemcr.2015.09.00410.1016/j.stemcr.2015.09.004 ↗
58. 10.1093/molehr/gam02710.1093/molehr/gam027 ↗
59. 10.1093/stmcls/sxad06510.1093/stmcls/sxad065 ↗
60. 10.3390/genes902009310.3390/genes9020093 ↗
61. 10.1371/journal.pone.000937010.1371/journal.pone.0009370 ↗
62. 10.1016/j.tcb.2010.05.00210.1016/j.tcb.2010.05.002 ↗
63. 10.1371/journal.pgen.100668210.1371/journal.pgen.1006682 ↗
64. 10.1038/labinvest.2015.14410.1038/labinvest.2015.144 ↗
65. 10.1101/gad.14.14.172910.1101/gad.14.14.1729 ↗
66. 10.1007/s13238-018-0560-510.1007/s13238-018-0560-5 ↗
67. 10.1371/journal.pone.012118510.1371/journal.pone.0121185 ↗
68. 10.3389/fcell.2021.64559310.3389/fcell.2021.645593 ↗
69. 10.1038/s41419-020-03356-210.1038/s41419-020-03356-2 ↗
70. 10.3389/fphys.2020.0014010.3389/fphys.2020.00140 ↗
71. 10.1095/biolreprod61.3.73110.1095/biolreprod61.3.731 ↗
72. 10.2337/db12-016110.2337/db12-0161 ↗
73. 10.1016/j.ygeno.2018.10.01410.1016/j.ygeno.2018.10.014 ↗
74. 10.2337/diabetes.50.10.236310.2337/diabetes.50.10.2363 ↗
75. 10.1371/journal.pone.015958110.1371/journal.pone.0159581 ↗
76. 10.1038/s41598-021-92054-w10.1038/s41598-021-92054-w ↗
77. 10.1002/embr.20143844710.1002/embr.201438447 ↗
78. 10.1016/0012-1606(87)90133-310.1016/0012-1606(87)90133-3 ↗
79. 10.1016/0165-3806(85)90211-110.1016/0165-3806(85)90211-1 ↗
80. 10.3389/fnins.2021.78116010.3389/fnins.2021.781160 ↗
81. Cooper G. M. · 2000
82. 10.1016/S0960-9822(99)80210-310.1016/S0960-9822(99)80210-3 ↗
83. 10.1371/journal.pgen.100091810.1371/journal.pgen.1000918 ↗
84. 10.1371/journal.pbio.300037810.1371/journal.pbio.3000378 ↗
85. 10.1016/j.cell.2019.05.04110.1016/j.cell.2019.05.041 ↗
86. 10.1073/pnas.140979711110.1073/pnas.1409797111 ↗
87. 10.1126/science.273.5273.35910.1126/science.273.5273.359 ↗
88. 10.1093/embo-reports/kve00810.1093/embo-reports/kve008 ↗
89. 10.1371/journal.pone.012576510.1371/journal.pone.0125765 ↗
90. 10.1093/emboj/18.5.122310.1093/emboj/18.5.1223 ↗
91. 10.1158/1541-7786.MCR-05-002810.1158/1541-7786.MCR-05-0028 ↗
92. 10.1016/j.jhep.2016.02.02810.1016/j.jhep.2016.02.028 ↗
93. 10.1681/ASN.200512135510.1681/ASN.2005121355 ↗
94. 10.1186/s12964-018-0285-310.1186/s12964-018-0285-3 ↗
95. 10.1152/ajprenal.00225.200410.1152/ajprenal.00225.2004 ↗
96. 10.1152/ajpcell.00379.201310.1152/ajpcell.00379.2013 ↗
97. 10.5527/wjn.v5.i1.2010.5527/wjn.v5.i1.20 ↗
98. 10.3390/cells912271010.3390/cells9122710 ↗
99. 10.1089/scd.2007.001410.1089/scd.2007.0014 ↗
100. 10.1038/nsb74910.1038/nsb749 ↗